TERAVOLT: Thoracic Cancers International COVID-19 Collaboration

Autor:	Whisenant, J.G., Trama, A., Torri, V., De Toma, A., Viscardi, G., Cortellini, A., Michielin, O., Barlesi, F., Dingemans, A.C., Van Meerbeeck, J., Pancaldi, V., Soo, R.A., Leighl, N.B., Peters, S., Wakelee, H., Garassino, M.C., Horn, L.
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	Betacoronavirus/isolation & purification Betacoronavirus/pathogenicity Coronavirus Infections/complications Coronavirus Infections/epidemiology Coronavirus Infections/therapy Coronavirus Infections/virology Global Burden of Disease Humans International Cooperation Intersectoral Collaboration Medical Oncology/organization & administration Medical Oncology/standards Pandemics Pneumonia Viral/complications Pneumonia Viral/epidemiology Pneumonia Viral/therapy Pneumonia Viral/virology Practice Guidelines as Topic Registries Thoracic Neoplasms/complications Thoracic Neoplasms/mortality Thoracic Neoplasms/therapy
Zdroj:	Cancer cell, vol. 37, no. 6, pp. 742-745
Popis:	Prior publications on small subsets of cancer patients infected with SARS CoV-2 have shown an increased risk of mortality compared to the general population. Furthermore, patients with thoracic malignancies are thought to be at particularly high risk given their older age, smoking habits, and pre-existing cardio-pulmonary comorbidities. For this reason, physicians around the world have formed TERAVOLT, a global consortium dedicated to understanding the impact of COVID-19 on patients with thoracic malignancies.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______1900::6e4d48d838af0f3874e52609838fb161 https://serval.unil.ch/notice/serval:BIB_F9BFA1700A3B Zobrazit plný text záznamu